Short answer · Medically reviewed summary · Last updated: 2026-05-08
Glioblastoma multiforme (GBM) has an estimated annual incidence of approximately 3.2 per 100,000 individuals in the United States, making it the most common malignant primary brain tumor in adults. While often classified as a rare disease due to its incidence rate, its aggressive nature and high mortality mean that prevalence estimates are lower than incidence, typically reflecting only those diagnosed within the last few years. Is Glioblastoma multiforme considered a rare disease? While Glioblastoma multiforme is the most frequent primary malignant brain tumor, it is classified as a rare condition by many international health organizations due to its low annual incidence.
1 people with Glioblastoma multiforme have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Glioblastoma multiforme?
Prevalence of Glioblastoma multiforme: how many people are affected worldwide, differences by sex and region, with sources.
Glioblastoma multiforme (GBM) has an estimated annual incidence of approximately 3.2 per 100,000 individuals in the United States, making it the most common malignant primary brain tumor in adults. While often classified as a rare disease due to its incidence rate, its aggressive nature and high mortality mean that prevalence estimates are lower than incidence, typically reflecting only those diagnosed within the last few years.
Is Glioblastoma multiforme considered a rare disease?
While Glioblastoma multiforme is the most frequent primary malignant brain tumor, it is classified as a rare condition by many international health organizations due to its low annual incidence. Accurate prevalence data for Glioblastoma multiforme is challenging to track because the survival rate is historically low, meaning the number of people living with the disease at any given time is significantly smaller than the number of new cases diagnosed each year.
Who is most affected by Glioblastoma multiforme?
Epidemiological data for Glioblastoma multiforme shows distinct demographic trends:
- Age of Onset: It is primarily a disease of adulthood, with a median age of diagnosis around 64 years; it is rare in children.
- Gender Distribution: Men are statistically more likely to be diagnosed with Glioblastoma multiforme than women, with an incidence ratio of approximately 1.6 to 1.
- Geographic/Ethnic Factors: Studies suggest a higher incidence in Caucasian populations compared to individuals of Asian or African descent, though research into these disparities is ongoing.
Why is accurate data for Glioblastoma multiforme difficult to obtain?
Determining the exact number of people living with Glioblastoma multiforme is complicated by diagnostic challenges. While modern neuroimaging (MRI) has improved detection, some cases in elderly patients may not undergo biopsy, leading to potential under-reporting. At DiseaseMaps.org, 85 people with Glioblastoma multiforme have joined our community, providing a vital real-world perspective that complements clinical statistics by highlighting the lived experience of patients beyond the initial diagnosis.
Next steps
- Consult with a neuro-oncologist to discuss current clinical trials and targeted molecular therapies.
- Join the DiseaseMaps.org community to connect with other patients and caregivers navigating the challenges of Glioblastoma multiforme.
- Utilize resources like the National Brain Tumor Society for specialized support and updated treatment information.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare team regarding your specific clinical situation.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Central Brain Tumor Registry of the United States (CBTRUS) Statistical Reports
- Orphanet: Portal for rare diseases and orphan drugs
- American Cancer Society: Cancer Facts & Figures
Posted Oct 4, 2017 by carolina 2000
